Review article: hypoxia and hepatic drug metabolism--clinical implications

Alimentary Pharmacology & Therapeutics
P W AngusR A Smallwood

Abstract

Most major pathways of hepatic drug metabolism are dependent on oxygen. Hepatic mixed-function oxidases use oxygen directly as a substrate, while many other enzyme systems are indirectly dependent on oxygen for the generation of essential co-factors, such as NAD+ and ATP. Studies in vitro show that many of these oxygen-dependent reactions are impaired by relatively minor reductions in oxygen supply, of a magnitude likely to be encountered in vivo. Phase I metabolism by mixed-function oxidases appears to be more sensitive to hypoxia than phase II drug conjugation, although the oxygen requirements of conjugation reactions, such as glucuronidation, may be greatly enhanced by poor nutrition or fasting. Studies in humans are few, but in general they affirm the potential importance of the effects of hypoxaemic states on hepatic drug elimination. On present evidence, special care should be taken in hypoxic patients with drugs extensively metabolized by the liver, particularly those which have a low therapeutic ratio.

References

Jan 1, 1978·Biochemical Pharmacology·P MoldéusA Norling
Jul 1, 1978·Clinical Pharmacokinetics·P du SouichM Gibaldi
Jul 1, 1978·Clinical Pharmacokinetics·R I Ogilvie
Mar 1, 1979·The American Journal of Physiology·S JiT Rich
Mar 1, 1978·British Journal of Clinical Pharmacology·S N AgnihotriG T Tucker
Jan 1, 1978·Biochemical Pharmacology·C J Fowler, B A Callingham
Jan 1, 1979·British Journal of Clinical Pharmacology·N VicunaH Schwertner
Aug 1, 1976·Archives of Surgery·S I Gelman
Oct 1, 1976·Acta Physiologica Scandinavica·J A LarsenA Munck
Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
May 1, 1989·Biochemical Pharmacology·P W AngusR A Smallwood
Mar 1, 1986·The Journal of Pharmacy and Pharmacology·R Miller, I F Oliver
Feb 15, 1986·Biochemical Pharmacology·R F MinchinM R Boyd
Oct 1, 1986·Clinical Pharmacology and Therapeutics·C LaybournM Døssing
Jan 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R G Thurman, F C Kauffman
Jan 1, 1973·Advances in Experimental Medicine and Biology·M KesslerJ Höper
Sep 1, 1974·The American Review of Respiratory Disease·M H Jacobs, R M Senior
Dec 1, 1971·European Journal of Clinical Pharmacology·E SotaniemiO Koivisto
Jun 1, 1969·The American Journal of Physiology·J ShoreyB Combes
May 1, 1984·The American Review of Respiratory Disease·L Letarte, P du Souich
May 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D B JonesN P Madsen
May 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K Jungermann, N Katz
May 15, 1981·Biochemical Pharmacology·D P Jones
Jan 1, 1958·Acta Anatomica·A M RAPPAPORT, G Y HIRAKI
Sep 1, 1948·The Journal of Clinical Investigation·J D Myers, J B Hickam

❮ Previous
Next ❯

Citations

Nov 1, 1993·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G R Park
Jan 1, 1993·Clinical and Experimental Pharmacology & Physiology·S L ElliottR A Smallwood
Jan 1, 1994·In Vitro Cellular & Developmental Biology. Animal·H O JaureguiC Mullon
Feb 1, 1997·Drug Metabolism Reviews·W W Lautt, M P Macedo
Mar 7, 2017·Clinical Pharmacology in Drug Development·Andrew H TalalIslam Younis
Jul 14, 2020·Frontiers in Bioengineering and Biotechnology·Benedikt ScheideckerYasuyuki Sakai
Nov 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H OhiM Hirobe
Dec 23, 1999·Pharmacology & Toxicology·D G Le CouteurA J McLean
Feb 5, 2005·European Journal of Clinical Pharmacology·Michael StreitWalter E Haefeli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.